Yuge Mao
Papers
1
Total Citations
2
H-Index
1
About
Yuge Mao is a dedicated clinical researcher whose work centers on hepatocellular carcinoma (HCC), one of the world’s most lethal and increasingly prevalent malignancies. Their key contributions lie in advancing both the basic understanding and clinical management of liver cancer, with a particular focus on improving early diagnosis and developing more effective therapeutic strategies. Mao’s most cited paper, a comprehensive 2016 review of HCC research, synthesizes critical progress in early specific detection and innovative treatments, serving as a valuable resource for clinicians and scientists navigating this challenging field. While their citation impact is still building, this work underscores Mao’s commitment to bridging laboratory discoveries with bedside applications—a vital approach in the fight against a cancer that claims hundreds of thousands of lives annually. By highlighting emerging diagnostic tools and therapies, Mao has helped shape the conversation around HCC management, offering a roadmap for future investigations. Their research reflects a persistent drive to translate scientific insight into tangible clinical benefits, making them a thoughtful contributor to the ongoing battle against hepatocellular carcinoma.
Research Focus
Key Achievements
Top Papers
- 1